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Abstract Je-Hyan Lee et al. have published a study on
cystatin C concentrations in the first 30 days of life in 127
pre-term and 119 term neonates in this edition of Pediatric
Nephrology, thereby closing a knowledge gap of detailed
cystatin C concentrations beyond 72 h of life by day of life
and by post-conceptional age. While the study objective has
merit and a large number of measurements were included,
there are some methodological limitations that bring the
validity of the data into question as pure reference intervals
for children up to 1 month of age, mostly because of the
inclusion of patients that potentially could have an impaired
glomerular filtration rate (GFR), for instance due to exposure to nephrotoxic drugs. We discuss the strengths and
weaknesses of the study and outline an approach to definitely close this knowledge gap. We call for a worldwide
collaboration to use Box–Cox transformations similar to the
methodology used with growth charts to calculate ageindependent z-scores and percentiles of neonatal and infant
markers of GFR. This could also lead to better definitions of
acute kidney injury in infants if GFR markers cross the
percentiles based on post-conceptional or chronological age.
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Introduction
Accurate measurements of renal function are important for the
dosing of drugs excreted by the kidneys. This is particularly
challenging in neonates. While all nephrons are terminally
differentiated at birth, they are recruited sequentially after
birth in a similar sequence as they were formed through
branching of the ureteric bud [1–3]. Renal function is typically
measured by assessment of the glomerular filtration rate
(GFR) [4], which is also important for assessing renal prognosis, especially in children with congenital renal anomalies
[5]. There is also an increased appreciation that nephron
endowment is not the same for every neonate and that congenital abnormalities may be associated with substantial nephron loss, especially if there was intermittent or persistent
increased pressure in the urinary collecting system. The key
mechanism is believed to be the induction of apoptosispromoting molecules by increased pressure in the urinary
collecting system [6]. However, there are challenges associated with the accurate assessment of GFR in neonates. Popper
and Mandel proposed the use of serum creatinine in 1937 [7],
and this measurement remains to this day the most widely
used marker for GFR estimation despite its shortcomings.
However, serum creatinine is largely affected by maternal
GFR as creatinine crosses the placenta [8]. Over the last
decade, cystatin C, a low molecular weight cysteine protease
that is constantly produced by all nucleated cells [9], has
evolved as a promising alternative to serum creatinine, with
a better diagnostic sensitivity [10] and independence of muscle mass [11] and body composition [12]. Currently, the best
estimated (e)GFR formulae in children can be derived from
cystatin C alone or in combination with creatinine and/or urea
[13]. Plebani et al. [14] and Cataldi et al. [15] have suggested
that cystatin C does not cross the placenta. Bökenkamp et al.
have shown that fetal cystatin C may be a useful predictor of
postnatal kidney function [16]. Some evidence for diaplacental transport of cystatin C has recently been presented [5, 17],
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Fig. 1 Relationship between
postnatal age (days), grouped
by gestational age, and cystatin
C concentrations as reported by
Ji-Hyan Lee et al. [20] based on
the results of their study at Soon
Chun Hyang University, Seoul,
Republic of Korea. The graph is
derived from data presented in
Table 2 of their article. While
term babies had the lowest
cystatin C concentrations and
maintained these low
concentrations throughout the
study period, the cystatin C
concentrations of premature
infants actually increased
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Serum cystatin C in the first 30 postnatal days
in neonates
Ji-Hyan Lee and colleagues measured cystatin C in 883
blood samples from 246 neonates, of whom 127 were premature. The exclusion criteria for prematurity were well
selected, even though it always remains a challenge to truly
define premature babies as healthy individuals. For premature babies with a post-conceptional age of <28 to 32 weeks,
the authors demonstrated a gradual decline of serum cystatin
C from 1.60±0.21 on day 0–3 to 1.50 mg/L on day 4–6,
followed by gradually increasing levels up to 22–30 days.
For full-term babies, the trends in cystatin C levels did not
show such marked changes from 0–3 day to 22–30 days.
The strengths of the study include the large number of
patients [15 infants at≤28 weeks of gestation, 40 at 29–32
weeks of gestation, 72 at 33–36 weeks of gestation, and 119
term infants (≥37 weeks of gestation)] and the large number
of measurements (883). However, some patients presented
with a wide variety of treatment procedures, with 34.1 and
31.0 % of measurements obtained while the patient was
ventilated or receiving nephrotoxic drugs, respectively.
This variation in treatment procedures significantly limits the designation of values presented in Table 2 of the
article as reference intervals. Interestingly, when all

groups were analyzed separately and longitudinally, the
cystatin C values can be seen to have increased slightly
(Fig. 1, derived from Table 2 in the article of Je-Hyan
Lee et al. [20]). The slope of the regression line of the
averages increases significantly in the extremely preterm
group. Because each of the four study groups comprises
a different number of infants, the results are heavily
weighted towards term infants.
Interestingly, there was no difference in cystatin C concentrations among the four gestational age groups during the
first 3 postnatal days. We had the opportunity to check the
results against our own data from a previous study and also
found no difference with regards to the initial cystatin C
values on day 3 of life (Fig. 2). The data in that study reflect
truly cross-sectional data.
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although the effect was much less pronounced than that of
serum creatinine, even 72 h postpartum. However, pediatric
reference intervals of cystatin C beyond 72 h postpartum to 1
year of age have to date lacked the necessary high resolution
of post-conceptual age that is necessary to assess the rapid
ontogeny of nephron recruitment in the first few months of life
[3, 5, 18, 19]. In that context, we are delighted to see an
important attempt at closing the knowledge gap, at least for
the first 30 days of life, in the study of Ji-Hyun Lee and
coworkers in this edition of Pediatric Nephrology [20].
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Fig. 2 The relationship between post-conceptional age in weeks and
serum cystatin C level on day 3 of life in 111 healthy term and pre-term
neonates from Children’s Hospital of Eastern Ontario. The slope of the
regression line was not significantly non-zero (Y=slope × X+ Y-intercept, with the slope=0.004080±0.005375, Y-intercept when X=0.0=
1.461±0.1751; p=0.4494)
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Future directions
There is clearly a need to assess whether the GFR is normal
in relationship to post-conceptional age. The GFR increases
by threefold by 24 h after delivery; this is followed by a
continuous slow increase until steady state is reached at 18
months [21]. Thereafter, the absolute GFR increases with
body length; as such, the GFR is normalized to body surface
area, which makes it an age-independent parameter, while
serum creatinine continues to increase [22]. In infants, even
with normalization to body surface area, GFR increases
from about 10 to 90–150 mL/min/1.73 m2 in 2-year-old
children [3]. Pediatric nephrologists have significant difficulties determining exactly what the normal GFR would be
for the exact age. Typically, reference intervals are provided
as the 2.5th and 97.5th percentile for a given age range, but
ideally, a modeled regression line using polynomial regression is more applicable to reflect the gradual changes. The
undersigned are only aware of one such model for serum
creatinine [23]. However, polynomial regression analysis
also does not allow for assessment of age-independent normal values.
So, how can we derive whether cystatin C (or creatinine)
or the eGFR derived from this [24] is actually normal for a
given age in days post conception or days of life for a term
infant? Luckily, an approach for a similar problem can be
applied to markers of GFR in the first 24 months of life,
namely the calculation of age-independent percentiles or zscores. The Center of Disease Control and the World Health
Organization have developed feasible and accurate methods
for calculating percentiles or z-scores for height, weight,
weight for height, and body mass index. We have applied
these to children with chronic kidney disease [25]. If a
sufficient sample size exists, Box–Cox transformations can
be applied to calculate age-independent z-scores. Briefly,
parameters of the median (M), the generalized coefficient
of variation (S), and the power in the Box–Cox transformation (L) are calculated to generate exact percentiles and zscores. To obtain the value (X) of a given physical measurement at a particular z-score or percentile, we used the following equation: X=M (1+LSZ)**(1/L), where L, M, and S
are the values corresponding to the age in months of the
child, and Z is the z-score that corresponds to the percentile.
An example can be found in a recent study on the effects of
preconception age of mothers on the body mass index
percentiles of their offspring [26]. For the current issue,
the aim is to collate cystatin C values of healthy infants less
than 2 years of age obtained in pooled samples from multiple centers with standardized cystatin C measurements. The
patient data need to be analyzed in sufficiently small age
groups for the calculation of the L, M, and S scores by day
for the first 4 weeks, thereafter by week until 6 months of
life, and thereafter monthly, then age-independent
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percentiles. This approach will determine cystatin C reference intervals based on post-conceptual age and on age in
days, and would assess whether a marker of renal function is
crossing percentiles or not. This method would also allow
for a much better way of assessing acute kidney injury in
neonates [3]. The undersigned call for a multicenter collaboration to identify all infant cystatin C measurements in
healthy children or children without any obvious disease
or nephrotoxic medication or dehydration to generate these
percentiles. Some of the measurements obtained by Je-Hyan
Lee et al. [20] can be included. We suggest that the
International Pediatric Nephrology Association could play
a key role in coordinating such efforts.

Conclusion
Je-Hyan Lee et al. [20] have made a significant contribution
towards closing the knowledge gap of cystatin C concentrations in the first month of life, despite the many limitations of their study. Further work and a coordinated effort
across the globe is needed to develop a useful tool using the
Box–Cox transformation of normal cystatin C data in
infants to generate appropriate LMS charts for the calculation of age-independent percentiles that will enable accurate
determination of the cystatin C percentiles based on postconceptional and postnatal age.
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